The p53 Arg72Pro and Ins16bp polymorphisms and their haplotypes are not associated with breast cancer risk in BRCA-mutation negative familial cases

Peto, 1999, Prevalence of BRCA1 and BRCA2 gene mutations in patients with early-onset breast cancer, J Natl Cancer Inst, 91, 943, 10.1093/jnci/91.11.943 2000, Prevalence and penetrance of BRCA1 and BRCA2 mutations in a population-based series of breast cancer cases, Br J Cancer, 83, 1301, 10.1054/bjoc.2000.1407 Pharoah, 2002, Polygenic susceptibility to breast cancer and implications for prevention, Nat Genet, 31, 33, 10.1038/ng853 Antoniou, 2003, Polygenic inheritance of breast cancer: implications for design of association studies, Genet Epidemiol, 25, 190, 10.1002/gepi.10261 Houlston, 2004, The search for low-penetrance cancer susceptibility alleles, Oncogene, 23, 6471, 10.1038/sj.onc.1207951 Easton, 2007, Genome-wide association study identifies novel breast cancer susceptibility loci, Nature, 447, 1087, 10.1038/nature05887 Simchoni, 2006, Familial clustering of site-specific cancer risks associated with BRCA1 and BRCA2 mutations in the Ashkenazi Jewish population, Proc Natl Acad Sci USA, 103, 3770, 10.1073/pnas.0511301103 Antoniou, 2008, Common breast cancer-predisposition alleles are associated with breast cancer risk in BRCA1 and BRCA2 mutation carriers, Am J Hum Genet, 4, 937, 10.1016/j.ajhg.2008.02.008 Breast Cancer Association Consortium, 2006, Commonly studied single-nucleotide polymorphisms and breast cancer: results from the Breast Cancer Association Consortium, J Natl Cancer Inst, 98, 1382, 10.1093/jnci/djj374 Wang-Gohrke, 2002, Intron 3 16 bp duplication polymorphism of p53 is associated with an increased risk for breast cancer by the age of 50 years, Pharmacogenetics, 12, 269, 10.1097/00008571-200204000-00012 Wirtenberger, 2006, Interaction of Werner and Bloom syndrome genes with p53 in familial breast cancer, Carcinogenesis, 27, 1655, 10.1093/carcin/bgi374 Osorio, 2006, A haplotype containing the p53 polymorphisms Ins16bp and Arg72Pro modifies cancer risk in BRCA2 mutation carriers, Hum Mutat, 27, 242, 10.1002/humu.20283 Buyru, 2007, p53 genotypes and haplotypes associated with risk of breast cancer, Cancer Detect Prev, 31, 207, 10.1016/j.cdp.2007.04.004 Manoukian, 2007, Germline mutations of TP53 and BRCA2 genes in breast cancer/sarcoma families, Eur J Cancer, 43, 601, 10.1016/j.ejca.2006.09.024 Suspitsin, 2003, Evidence against involvement of p53 polymorphism in breast cancer predisposition, Int J Cancer, 103, 431, 10.1002/ijc.10834 Jonkers, 2001, Synergistic tumor suppressor activity of BRCA2 and p53 in a conditional mouse model for breast cancer, Nat Genet, 29, 418, 10.1038/ng747